The estimation of paracetamol and orphenadrine citrate in a multicomponent pharmaceutical dosage form by spectrophotometric method has been reported. Because of highly interference in the spectra and the presence of non-linearity caused by the analyte concentrations which deviate from Beer and Lambert's law, partial least-squares (PLS) and artiˆ-cial neural networks (ANN) techniques were used for the calibration. A validation set of spiked samples was employed for testing the accuracy and precision of the methods. Reasonably good recoveries were obtained with PLS for paracetamol and the use of an ANN allowed the estimation of orphenadrine citrate, a minor component which could not be adequately modeled by PLS. Three production batches of a commercial sample were analysed, and there was statistically no signiˆcant diŠerence (P＜0.05) between the results with the proposed method and those obtain with the o‹cial comparative method.
INTRODUCTION
One of the determination techniques most frequently used in pharmaceutical analysis is UV-VIS spectrophotometry because of the robustness, ease of operation, rapid response as well as low purchase and maintenance costs. However, the lack of speciˆcity of the UV-absorption of components in a multicomponent drug formulation usually hinders the application of this technique, due to spectral overlap. More recently, a group of methods known as`multivariate calibration' such as multiple linear regression (MLR), principal component regression (PCR) and partial least-squares (PLS) have been found to play important roles in analytical chemistry and they are capable of analysing and modeling hundreds of experimental data, making it possible to determine multiple components of interest simultaneously. Among them, PLS has found important applications in pharmaceutical analysis. 1) This method is useful for the resolution of complex mixtures of analytes and the spectra of which are strongly overlapping. 2) Although PLS assumes a linear relationship between the measured sample concentrations and the intensity of its absorption bands, small deviations from linearity are acceptable as they can readily be suppressed by including additional modeling factors. 3) However, in the presence of substantial non-linearity, PLS tends to give large prediction errors and calls for more robust models such as artiˆcial neural networks (ANN). 4) Artiˆcial neural networks are computer methods that simulate learning and generalization behavior of the human brain through data modeling and pattern recognition for complicated multidimensional problems. A signiˆcant diŠerence between an ANN model and a statistical model is that the ANN can generalize the relationship between independent and dependent variables without a speciˆc mathematical function. Thus, an ANN works well for solving nonlinear problems of multivariate and multi-response systems. The ANN has been used in a variety of disciplines, such as chemistry and chemical engineering. For example, the ANN technique has been applied to several analytical methods, such as nuclear magnetic resonance, 5) high-performance liquid chromatography, 6) infrared spectroscopy, 7) mass spectroscopy, 8) and UV-VIS spectroscopy. 9) It has also proved useful for resolving mixtures of analytes giving deviate signal form Beer and Lambert's Law in spectrophotometric techniques. 10) Paracetamol (4-acetamidophenol) is an eŠective 30  2  12  20  2  2  10  2  13  10  0  3  20  1  14  15  0  4  20  3  15  20  0  5  25  1.5  16  25  0  6  25  2.5  17  30  0  7  1 5  1 . 5  1 8  0  1  8  1 5  2 . 5  1 9  0  1 . 5  9  2 0  2  2 0  0  2  1 0  2 0  2  2 1  0  2 . 5  1 1  2 0  2  2 2  0  3 13 16) or in combination with other drugs, 17 19) no spectrophotometric method has been reported for the simultaneous determination of these two compounds in pharmaceutical tablets.
In this report, we study the possibility of the estimation of paracetamol and orphenadrine citrate in pharmaceutical dosage form, which has highly diŠer-ence in proportions of two active ingredients by PLS and ANN. Each tablet contains paracetamol 500 mg and orphenadrine citrate 35 mg (in the ratio about 14 : 1 (PAR : OPC)). When both active constituents are to be simultaneously estimated with a single spectrum measurement, the major analyte (PAR) would be present in concentrations which deviate from Beer and Lambert's law and the minor analyte (OPC) would be in concentration near to the noise level. In our study, PAR can be estimated with PLS method. On the other hand, OPC requires the use of an ANN since it is apparent non-linearity that cannot be adequately modeled by PLS.
MATERIALS AND METHODS

Apparatus and Software
Electronic absorption measurements were carried out on a Shimadzu UV160A spectrophotometer connected to a computer loaded with Shimadzu UVPC software, using quarts cells with a 1-cm path length. The absorption spectra of all test and reference solutions were recorded each 1 nm in the range 200 300 nm. The obtained data were processed by a Pentium IV computer having 512 MB for RAM (Windows XP operating system). The PLS was performed by PLS_Toolbox 2.0 20) under MATLAB 7.0 21) and the ANN was implemented in MATLAB 7.0 using the additional Neural Network Toolbox. 21) Chromatographic measurements were carried out in a high-performance liquid chromatography Shimudzu LC-20AT, equipped with single pump, a 243-nm detector, manual injector (20 ml) and a 4.6-mm× 25-cm column that contains packing ODS (C-18). The mobile phase was 75％ of water and 25％ of methanol.
Reagents All experiments were performed with pharmaceutical-grade PAR and OPC and analyticalgrade reagents. Tablets containing PAR and OPC were kindly supplied by manufacturer (SEA PHARM Co., Ltd., Thailand). The preparations contain 500 mg of PAR, 35 mg of OPC and excipients (EXP) such as lactose, corn starch, magnesium stearate, microcrystalline cellulose and sodium starch glycolate. Stock solutions of PAR (150 and 170 mg L -1 ), OPC (12.5 and 25 mg L -1 ) and EXP (50 mg L -1 ) were prepared by dissolving accurately weighed amounts of the drugs in methanol-water
Calibration Set Artiˆcial, a training set of 22 samples corresponding to central composite design with three centre samples and 10 pure samples was built to be used as calibration set for PLS. The compositions of the mixtures used in the calibration set were summarized in Table 1 . For the application of ANN, there are constraints concerning the number of samples, which at times may be limiting the development of an ANN model. The number of adjustable parameters (synaptic weights) is such that the calibration set is rapidly overˆtted if too few training pairs are available leading to loss of generalization ability. Therefore, calibration set of 77 samples corresponding to central composite design with three centre samples and mixture design of PAR and OPC in a matrix of excipients was used. A representative distribution of the concentration of PAR and OPC Fig. 1 . This set was composed of 4 groups. Each group was prepared on diŠerent days in order to take into account the maximum possible variability on the data. The set of 77 samples was randomly divided into a training set (65 samples) and a monitoring set (12 samples). All samples were obtained by serial dilution of the stock solutions in 25-ml volumetric ‰asks with methanol-water 
Spiked Sample Preparations
One set ofˆve synthetic samples on each compound (no.1 5 for PAR, no.6 10 for OPC) were prepared, using spike placebo technique, to validate the PLS model and ANN model. In Table 2 the compositions of these synthetic mixtures have been summarized.
Commercial Sample Preparation Three production batches of a commercial pharmaceutical formulation were evaluated. In this case, groups of 20 tablets were weighed,ˆnely powdered and mixed.
Portions of the powder equivalent to about 170 mg of PAR and 12 mg of OPC were accurately weighed and transferred to 250 ml volumetric ‰asks using 150 ml of methanol-water (1:3, v/v). After being continuously shaken for 20 min, the ‰asks were made up to volume with the same solvent, and the solids werê ltered, then, 5 ml aliquots were transferred from each ‰ask to 100 ml volumetric ‰asks and completed to volume with the same solvent. Each batch was analysed in three replicate.
RESULTS AND DISCUSSION
Spectral Features
The highly interference of the individual spectra of two drugs at equal concentrations (12 mg L -1 ) are shown in Fig. 2 . The spectra at the same solvent, but with analyte concentrations corresponding to sample diluted 1/15000: PAR, 33 mg L -1 , and OPC, 2.3 mg L -1 are shown in Fig. 3 . As can be seen in Fig. 3 , the minor analyte's concentration (OPC) is near to the noise level (absorbance is under 0.05), while that for the major analyte (PAR) is near to a concentration level, which deviates from Beer and Lambert's law (absorbance's rang between 2 and 2.5). Therefore, in order to simultaneously estimate both constituents, it may introduce to deviations of the absorbance/concentration linearity for the major and the minor analytes.
PLS Modeling
In the case of PLS, the absorption spectra for the calibration samples were recorded in the wavelength range of 200 300 nm and then subjected to PLS analysis. Although PLS is usually considered as a full spectrum method, literature shows a growing tendency to perform variable selection before multivariate regression, in order to improve its predicting ability. Many diŠerent procedures have been published for wavelength selection. 22) In this study, we have employed a moving window strategy to the calibration set in order toˆnd the location of the minimum calibration variance 23) . Even though the technique is very necessary, it should not be blindly applied. It should be checking the overlapping of the spectroscopic signal of the analytes at hand after selecting an appropriate spectral region. In our case, the selected regions were 211 235 nm for PAR and 206 220 nm for OPC because the absorbance in the other ranges were reached a concentration level, which deviates from Beer and Lambert's law (absorbances are over 2 or under 0.05). Once the optimum spectral ranges were selected, a cross-validation method using leave one out, was applied to select the number of principal components (PCs). The crossvalidation procedure consists of systematically removing one of the training samples in turn, and using only the remaining ones for construction of the latent factors and regression. The predicted concentrations were then compared with the actual ones for each of calibration samples, and the root mean square of error of cross-validation (RMSECV) was calculated. The RMSECV was computed in the same manner, each time a new principal component was added to the PLS model. The method described by Haaland and Thomas 24) was used for selecting the optimum number of PCs. Three PCs and 7 PCs were found suitable for PLS models of PAR and OPC, respectively. The calibration PLS models were established by PLS_Toolbox 2.0 program with these optimum parameters. Table 3 and 4 show the result obtained when applying each PLS model for PAR and OPC to the spiked samples.
It can be seen from Table 3 and 4 that the statistical parameters are good for PAR, but those are poor for OPC due to severe interference occurring between OPC and more concentrated PAR. Thus, ANN technique could be used for the estimation of OPC to handle this intrinsically non-linearity.
ANN Modeling
When the presence of nonlinearity was found and cannot be modeled by linear model such as PLS, one can apply ANN. Although ANN are also able to deal with a linear behavior and can often improve the results in comparison with a linear model, they are calibration techniques especially constructed to model non-linear information. In this application, the set of 77 samples was used as calibration set for ANN. This set was randomly divided into a training set (65 samples) and a monitoring set (12 samples). The calibration ANN model was established by MATLAB Neural Network Toolbox 2.0 program. This ANN model consisted of three layers of neurons or nodes, which were the basic computing units: the input layer with a number of active neurons corresponding to the scores, one hidden layer with a number of active neurons, and the output layer with one active neuron corresponding to the scaled concentration of the component of interest. The neurons were fully connected in a hierarchical manner, i.e. the outputs of one layer of nodes were used as inputs for the next layer and so on. The nodes in the input layer transfer the input data to all nodes in hidden layer. These nodes calculate a weighted sum of the inputs that is subsequently subjected to a non-linear transformation: 
where s i is the input to node i in the input layer, I is the number of nodes in the input layer, w ij (weights) are the connections between each node i in the input layer and each node j in hidden layer, w bj is the bias to node j and o j is the output of node j in hidden layer, and f is a non-linear function. In this work we have used the tan-sigmoid function (Eq. (2)) to increase the convergence speed. 25) f (x)＝ e x -e -x e x ＋e -x (2)
The tan-sigmoid hidden layer is critical as it allows the network to learn non-linear relationships between inputs and outputs. Linear functions are used in both the input and output layers. The learning process was carried out through the back-propagation algorithm. The back-propagation network learns by calculating an error between desired and actual output and propagating this error information back to each node in the network. This back-propagation error is used to drive the learning at each node. The process of changing the weight of the connections to achieve some desired result is called learning or adaptation.
In the present work the number of neurons in the hidden layer, momentum and learning rate were optimized. At this point, the mean square error (MSE) was calculated, each time a new node was added to the hidden layer at arbitrary learning rate, momentum and the number of iterations. The number of neurons at the hidden layer, which has the minimum MSE value, was selected as the optimum number. After this step, the learning rate was varies from 0.1 to 0.9, and for each learning rate the momentum was examined from 0.1 to 0.9. A total of 81 networks were designed in this way. Each network was trained with training set, but it was subsequently stopped before it learns idiosyncrasies present in the training data by searching the minimum MSE for the test set (monitoring set). Finally, the number of the neurons at the hidden layer with the use of optimized momentum and learning rate was determined. Figure 4 shows the stopping point, which was obtained at 25000 epochs for best ANN found for OPC. The summary speciˆcations for the network created for the calibrations were listed in Table 5 .
For accuracy studies, by recovery,ˆve spiked samples were analysed. The recovery values of OPC, obtained using ANN calibration model are shown in Table 6. They illustrate the reasonable good recovery values in most of the samples analysed.
Analysis of Tablet Dosage Form
Once upon optimized PLS model for PAR and ANN model for OPC, a commercial sample was analysed in according with the foregoing procedures. The intermediate pre- cision of the proposed methods was evaluated over six consecutive days by performing six absoption spectrophotometric records each day and was expressed as the standard deviation (SD) and relative standard deviation (RSD). In Table 7 , the results illustrate that the repeatability for both active ingredients on each day is satisfactory. The proposed methods were applied to the determination of PAR and OPC in pharmaceutical tablets for three production batches (batches A, B and C). Statistical analysis of the results obtained by the suggested spectrophotometric procedures has been also carried out. Table 8 shows the results of paired ttest for a comparison of the proposed procedures with the o‹cial procedures. The o‹cial methods for PAR and OPC were followed to USP 26 methods 13) . The calculated t-values are less than their corresponding tabulated ones, indicating no signiˆcant diŠer-ences between the suggested procedures and the reference procedures. The suggested procedures surpass the comparing ones so they can be used to determine PAR and OPC in pharmaceutical tablets.
CONCLUSIONS
This work illustrated the potential of the estimation of two drugs in tablet preparations, which have highly interference of the spectra and have the presence of non-linearity cause by the analyte concentrations, which deviate from Beer and Lambert's law. A validation set of spiked samples and a commercial sample were employed for testing the accuracy and precision of the methods. Reasonably good recoveries were obtained with PLS for PAR and the use of an ANN allowed the estimation of OPC, a minor component, which could not be adequately modeled by PLS. In ANN, too many samples were used to train the network. This makes it expensive in time and resources to develop for use in routine work. Thus, PLS method should be expected to give the best of choice in data set where linear response is observed. However, when non-linear response is present, artiˆ-cial neural networks may be capable of giving superior performance for spectrophotometric calibration. Due to the rapid calculation of the predictive results of very large samples, ANN approach is an eŠective choice for developing new analytical methods for in-process control in pharmaceutical manufacturing, which concern with several evaluated samples.
